Overview

A Study of T-20 in HIV-Positive Adults

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if it is safe and effective to give T-20 to HIV-positive adults. T-20 is an anti-HIV drug.
Phase:
Phase 2
Details
Lead Sponsor:
Trimeris
Treatments:
Enfuvirtide